SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy have?
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has 21 citations in the OpenAlex counts ScholarIQ stores.
When was SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy published?
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has 2023 year in the ScholarIQ index.
What is the open-access status of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?
The DOI for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.
What is the PMID of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?
The PMID for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.
What is the OpenAlex record for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?
The OpenAlex for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.